Advertisement

The clinical investigator

, Volume 71, Issue 1, pp 3–6 | Cite as

Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke Basel Prospective Study

  • K. F. Gey
  • H. B. Stähelin
  • M. Eichholzer
Original Articles

Summary

Previous cross-cultural comparisons of the mortality from ischemic heart disease in European communities with associated plasma levels of essential antioxidants have revealed strong inverse correlations for vitamin E and relatively weak correlations for other antioxidants. Similarly, in a case-control study in Edinburgh low plasma levels of vitamin E were significantly associated with an increased risk of previously undiagnosed angina pectoris whereas low levels of other essential antioxidants lacked statistical significance. The current Basel Prospective Study is particularly well suited to elucidate the impact of antioxidants other than vitamin E. In this population (which was recently evaluated regarding cancer mortality) the plasma levels of vitamins E and A are exceptionally high and above the presumed threshold level of risk for ischemic heart disease. The present 12-year follow-up of cardiovascular mortality in this study reveals a significantly increased relative risk of ischemic heart disease and stroke at initially low plasma levels of carotene (< 0.23 μmol/l) and/or vitamin C (< 22.7 μmol/l), independently of vitamin E and of the classical cardiovascular risk factors. Low levels of both carotene and vitamin C increase the risk further, in the case of stroke even with significance for overmultiplicative interaction. In conclusion, in cardiovascular disease independent inverse correlations may exist for every major essential antioxidant although the latter can also interact synergistically. Therefore future intervention trials of antioxidants in the prevention of ischemic heart disease should primarily test the simultaneous optimization of the status of all principal essential antioxidants.

Key words

Antioxidants Ischemic heart disease Stroke Vitamin C Carotene 

Abbreviations

CVD

cardiovascular disease

IHD

ischemic heart disease

LDL

low-density lipoproteins

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brubacher GB, Vuilleumier JP (1974) Procedure for the determination of vitamin C in plasma. In: Curtius HC, Roth M (eds) Clinical biochemistry principles and methods. de Gruyter, Berlin, pp 992–997Google Scholar
  2. 2.
    Editorial (1992) Atherosclerosis goes to the wall. Lancet 339:467–468Google Scholar
  3. 3.
    Enstrom JE, Kanim LE, Klein MA (1992) Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3:194–202Google Scholar
  4. 4.
    Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G, Rabl H (1991) Effect of antioxidants on oxidative modification of LDL. Ann Med 23:573–581Google Scholar
  5. 5.
    Frei B (1991) Ascorbic acid protects lipids in human blood plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 54:1113S–1118SGoogle Scholar
  6. 6.
    Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH (1990) Beta carotene therapy for chronic stable angina. Circulation 82 [Suppl III]: 201Google Scholar
  7. 7.
    Gey KF (1986) On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 37:53–91Google Scholar
  8. 8.
    Gey KF (1992) Vitamin E and other essential antioxidants regarding coronary heart disease: risk assessment studies. Review in: Packer L, FuchsJ (eds) Vitamin B: biochemistry and clincial applications. Dekker, New York, pp 589–633Google Scholar
  9. 9.
    Gey KF, Puska P, Jordan P, Moser UK (1991) Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 53:326S–334SGoogle Scholar
  10. 10.
    Harats D, Ben-Naim M, Dabach Y, Hollander G, Havivi E, Stein O, Stein Y (1990) Effect of vitamin C and E supplementation on susceptability of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 85:47–54Google Scholar
  11. 11.
    Jialal I, Vega GL, Grundy SM (1990) Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 82:185–191Google Scholar
  12. 12.
    Manson JE, Stampfer MJ, Willett WC et al. (1991) A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation 84 [Suppl II]:546Google Scholar
  13. 13.
    Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF (1991) Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 337:1–5Google Scholar
  14. 14.
    Stähelin HB, Gey KF, Eichholzer M et al. (1991) Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the Prospective Basel Study. Am J Epidemiol 133:766–775Google Scholar
  15. 15.
    Steinberg D (1992) Summary of the proceedings of a NHLBI workshop: Antioxidants in the Prevention of Human Atherosclerosis, September 5–6, 1991, Bethesda. Circulation 85:2338–2344Google Scholar
  16. 16.
    Wartanowicz M, Panczenkof Kresowska B, Ziemlanski S, Kowalska M, Okolska G (1984) The effect of a-tocopherol and ascorbic acid on the serum lipid peroxide level in elderly people. Ann Nutr Metab 28:186–191Google Scholar
  17. 17.
    Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785–1792PubMedGoogle Scholar
  18. 18.
    Vuilleumier JP, Keller HE, Gysel D, Hunziker F (1983) Clinical chemical methods for the routine assessment of the vitamin status in human populations. I. The fat-soluble vitamins A and E, and β-carotene. Int J Vitam Nutr Res 53:262–272Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • K. F. Gey
    • 1
  • H. B. Stähelin
    • 1
  • M. Eichholzer
    • 2
  1. 1.Vitamin- ForschungseinheitInstitut für Biochemie and Molekularbiologie Universität BernBernSwitzerland
  2. 2.Geriatrische Universitätsklinik, Kantonsspital, Universität BaselSwitzerland

Personalised recommendations